Review
DOI DOI: 10.62063/rev-11

Unraveling Epilepsy: Investigating stem cell approaches for innovative treatment and future cure

Hilal Balcilar1, Sajeda Osman1, Sevim Isik2
  1. 1 Uskudar University
  2. 2 Üsküdar University

Abstract

Epilepsy is a persistent neurological disorder characterized by repeated, spontaneous seizures that arise without a specific cause. These seizures result from abnormal electrical activity in the brain, leading to a range of symptoms, from brief periods of unconsciousness or minor sensory disturbances to severe convulsions. The management of epilepsy remains a significant challenge, as current treatment modalities, primarily involving antiepileptic drugs and surgical interventions to remove seizure foci, often provide adequate control for a substantial portion of patients. For this reason, stem cell therapies have become a hopeful approach because of their ability to potentially restore and renew impaired neural networks, which is particularly relevant for neurological disorders like epilepsy. This review investigates the present state of stem cell therapies in epilepsy, analyzing distinct types of stem cells, their mode of action, preclinical and clinical trials, as well as future research prospects.

How to Cite

Balcilar, H., Osman, S., & Isik, S. (2025). Unraveling Epilepsy: Investigating stem cell approaches for innovative treatment and future cure . EUCHEMBIOJ Reviews, 1(1), e25002. https://doi.org/10.62063/rev-11
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Abdanipour, A., Tiraihi, T., & Mirnajafi-Zadeh, J. (2011). Improvement of the pilocarpine epilepsy model in rat using bone marrow stromal cell therapy. Neurological research, 33(6), 625–632. https://doi.org/10.1179/1743132810Y.0000000018
  2. Alayli, A., Lockard, G., Gordon, J., Connolly, J., Monsour, M., Schimmel, S., Dela Peña, I., & Borlongan, C. V. (2023). Stem Cells: Recent Developments Redefining Epilepsy Therapy. Cell transplantation, 32, 9636897231158967. https://doi.org/10.1177/09636897231158967
  3. Bond, A. M., Ming, G. L., & Song, H. (2015). Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later. Cell stem cell, 17(4), 385–395. https://doi.org/10.1016/j.stem.2015.09.003
  4. Chang, B. L., & Chang, K. H. (2022). Stem Cell Therapy in Treating Epilepsy. Frontiers in neuroscience, 16, 934507. https://doi.org/10.3389/fnins.2022.934507
  5. DaCosta, J. C., Portuguez, M. W., Marinowic, D. R., Schilling, L. P., Torres, C. M., DaCosta, D. I., Carrion, M. J. M., Raupp, E. F., Machado, D. C., Soder, R. B., Lardi, S. L., & Garicochea, B. (2018). Safety and seizure control in patients with mesial temporal lobe epilepsy treated with regional superselective intra-arterial injection of autologous bone marrow mononuclear cells. Journal of tissue engineering and regenerative medicine, 12(2), e648–e656. https://doi.org/10.1002/term.2334
  6. Das, M., Mayilsamy, K., Mohapatra, S. S., & Mohapatra, S. (2019). Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects. Reviews in the neurosciences, 30(8), 839–855. https://doi.org/10.1515/revneuro-2019-0002
  7. Datta, D., Subburaju, S., Kaye, S., Baruah, J., Choi, Y. K., Nian, Y., Khalili, J. S., Chung, S., Elkhal, A., & Vasudevan, A. (2020). Human forebrain endothelial cell therapy for psychiatric disorders. Molecular Psychiatry 2020 26:9, 26(9), 4864–4883. https://doi.org/10.1038/s41380-020-0839-9
  8. de Gois da Silva, M. L., da Silva Oliveira, G. L., de Oliveira Bezerra, D., da Rocha Neto, H. J., Feitosa, M. L. T., Argôlo Neto, N. M., Rizzo, M. D. S., & de Carvalho, M. A. M. (2018). Neurochemical properties of neurospheres infusion in experimental-induced seizures. Tissue & cell, 54, 47–54. https://doi.org/10.1016/j.tice.2018.08.002
  9. Dubé, C. M., Brewster, A. L., Richichi, C., Zha, Q., & Baram, T. Z. (2007). Fever, febrile seizures and epilepsy. Trends in neurosciences, 30(10), 490–496. https://doi.org/10.1016/J.TINS.2007.07.006
  10. French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., Bergen, D., Hirtz, D., Montouris, G. D., Nespeca, M., Gidal, B., Marks, W. J., Turk, W. R., Fischer, J. H., Bourgeois, B., … Glauser, T. A. (2004). Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New-Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 45(5), 401–409. https://doi.org/10.1111/J.0013-9580.2004.06204.X
  11. Fukumura, S., Sasaki, M., Kataoka-Sasaki, Y., Oka, S., Nakazaki, M., Nagahama, H., Morita, T., Sakai, T., Tsutsumi, H., Kocsis, J. D., & Honmou, O. (2018). Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus. Epilepsy Research, 141, 56–63. https://doi.org/10.1016/J.EPLEPSYRES.2018.02.008
  12. Guerreiro, C. A. M. (2016). Epilepsy: Is there hope? The Indian Journal of Medical Research, 144(5), 657. https://doi.org/10.4103/IJMR.IJMR_1051_16
  13. Hirose, S., Tanaka, Y., Shibata, M., Kimura, Y., Ishikawa, M., Higurashi, N., Yamamoto, T., Ichise, E., Chiyonobu, T., & Ishii, A. (2020). Application of induced pluripotent stem cells in epilepsy. Molecular and Cellular Neuroscience, 108, 103535. https://doi.org/10.1016/J.MCN.2020.103535
  14. Hlebokazov, F., Dakukina, T., Ihnatsenko, S., Kosmacheva, S., Potapnev, M., Shakhbazau, A., Goncharova, N., Makhrov, M., Korolevich, P., Misyuk, N., Dakukina, V., Shamruk, I., Slobina, E., & Marchuk, S. (2017). Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study. Advances in Medical Sciences, 62(2), 273–279. https://doi.org/10.1016/J.ADVMS.2016.12.004
  15. Hlebokazov, F., Dakukina, T., Potapnev, M., Kosmacheva, S., Moroz, L., Misiuk, N., Golubeva, T., Slobina, E., Krasko, O., Shakhbazau, A., Hlavinski, I., & Goncharova, N. (2021). Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients. Clinical Neurology and Neurosurgery, 207. https://doi.org/10.1016/J.CLINEURO.2021.106736
  16. Huang, P. Y., Shih, Y. H., Tseng, Y. J., Ko, T. L., Fu, Y. S., & Lin, Y. Y. (2016). Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly as a potential therapy for rat pilocarpine-induced epilepsy. Brain, behavior, and immunity, 54, 45–58. https://doi.org/10.1016/j.bbi.2015.12.021
  17. Jiang, M., Ye, J., Wang, X., Li, N., Wang, Y., & Shi, Y. (2020). Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals. Cell and Bioscience, 10(1), 1–10.
  18. https://doi.org/10.1186/S13578-020-00428-W/FIGURES/4
  19. Johnson, E. L. (2019). Seizures and Epilepsy. The Medical Clinics of North America, 103(2), 309-324. https://doi.org/10.1016/J.MCNA.2018.10.002
  20. Klein, P., Kaminski, R. M., Koepp, M., & Löscher, W. (2024). New epilepsy therapies in development. Nature Reviews. Drug Discovery. https://doi.org/10.1038/S41573-024-00981-W
  21. Kodali, M., Castro, O. W., Kim, D. K., Thomas, A., Shuai, B., Attaluri, S., Upadhya, R., Gitai, D., Madhu, L. N., Prockop, D. J., & Shetty, A. K. (2019). Intranasally Administered Human MSC Derived Extracellular Vesicles Pervasively Incorporate into Neurons and Microglia in both Intactand Status Epilepticus Injured Forebrain. International Journal of Molecular Sciences 2020, Vol. 21, Page 181, 21(1), 181. https://doi.org/10.3390/IJMS21010181
  22. Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Hauser, W. A., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010). Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51(6), 1069–1077. https://doi.org/10.1111/J.1528-1167.2009.02397.X
  23. Kwan, P., Schachter, S. C., & Brodie, M. J. (2011). Drug-resistant epilepsy. New England Journal of Medicine, 365(10), 919–926. https://doi.org/https://doi.org/10.1056/nejmra1004418
  24. Lee, V. L. L., Choo, B. K. M., Chung, Y. S., Kundap, U. P., Kumari, Y., & Shaikh, M. F. (2018). Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review. International Journal of Molecular Sciences, 19(3). https://doi.org/10.3390/IJMS19030871
  25. Liu, G., Health, A., Slater, N., & Perkins, A. (2017). Epilepsy: Treatment Options. American Family Physician, 96(2), 87–96. https://www.aafp.org/pubs/afp/issues/2017/0715/p87.html
  26. Liu, Z. Z., Huang, Y., Hong, C. G., Wang, X., Duan, R., Liu, J. Y., He, J. L., Duan, D., Xie, H., & Lu, M. (2023). Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy. Stem Cell Research and Therapy, 14(1), 1–16. https://doi.org/10.1186/S13287-023-03458-6/FIGURES/8
  27. St Louis E. K. (2009). Truly “rational” polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects. Current neuropharmacology, 7(2), 96–105. https://doi.org/10.2174/157015909788848929
  28. Lybrand, Z. R., Goswami, S., & Hsieh, J. (2020). Stem cells: a path towards improved epilepsy therapies. Neuropharmacology, 168, 107781. https://doi.org/10.1016/J.NEUROPHARM.2019.107781
  29. McNamara, J. O. (1999). Emerging insights into the genesis of epilepsy. Nature, 399(6738 Suppl). https://doi.org/10.1038/399A015
  30. Miguel Sanz, C., Martinez Navarro, M., Caballero Diaz, D., Sanchez-Elexpuru, G., & di Donato, V. (2023). Toward the use of novel alternative methods in epilepsy modeling and drug discovery. Frontiers in Neurology, 14, 1213969. https://doi.org/10.3389/FNEUR.2023.1213969/BIBTEX
  31. Milczarek, O., Jarocha, D., Starowicz–Filip, A., Kwiatkowski, S., Badyra, B., & Majka, M. (2018). Multiple Autologous Bone Marrow–Derived CD271+ Mesenchymal Stem Cell Transplantation Overcomes Drug–Resistant Epilepsy in Children. Stem Cells Translational Medicine, 7(1), 20. https://doi.org/10.1002/SCTM.17-0041
  32. Mohammed, A. S., Ewais, M. M., Tawfik, M. K., & Essawy, S. S. (2014). Effects of intravenous human umbilical cord blood mesenchymal stem cell therapy versus gabapentin in pentylenetetrazole-induced chronic epilepsy in rats. Pharmacology, 94(1–2), 41–50. https://doi.org/10.1159/000365219
  33. Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., Abraham, J., Ackerman, I., Aggarwal, R., Ahn, S. Y., Ali, M. K., AlMazroa, M. A., Alvarado, M., Anderson, H. R., … Lopez, A. D. (2012). Disability adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380(9859), 2197–2223. https://doi.org/10.1016/S0140-6736(12)61689-4
  34. Nair, D. R. (2016). Management of Drug-Resistant Epilepsy. Continuum (Minneapolis, Minn.), 22(1Epilepsy), 157–172. https://doi.org/10.1212/CON.0000000000000297
  35. Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., Whitney, A., & Cross, J. H. (2008). The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. The Lancet Neurology, 7(6), 500–506. https://doi.org/10.1016/S14744422(08)70092-9
  36. Papazian, I., Kyrargyri, V., Evangelidou, M., Voulgari-Kokota, A., & Probert, L. (2018). Mesenchymal Stem Cell Protection of Neurons against Glutamate Excitotoxicity Involves Reduction of NMDA Triggered Calcium Responses and Surface GluR1, and Is Partly Mediated by TNF. International Journal of Molecular Sciences 2018, Vol. 19, Page 651, 19(3), 651. https://doi.org/10.3390/IJMS19030651
  37. Patel, D. C., Tewari, B. P., Chaunsali, L., & Sontheimer, H. (2019). Neuron-glia interactions in the pathophysiology of epilepsy. Nature Reviews. Neuroscience, 20(5), 282–297. https://doi.org/10.1038/S41583-019-0126-4
  38. Poppe, D., Doerr, J., Schneider, M., Wilkens, R., Steinbeck, J. A., Ladewig, J., Tam, A., Paschon, D. E., Gregory, P. D., Reik, A., Müller, C. E., Koch, P., & Brüstle, O. (2018). Genome Editing in Neuroepithelial Stem Cells to Generate Human Neurons with High Adenosine-Releasing Capacity. Stem Cells Translational Medicine, 7(6), 477–486. https://doi.org/10.1002/SCTM.16-0272
  39. Riva, A., Golda, A., Balagura, G., Amadori, E., Vari, M. S., Piccolo, G., Iacomino, M., Lattanzi, S., Salpietro, V., Minetti, C., & Striano, P. (2021). New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment. Frontiers in Neurology, 12, 753753. https://doi.org/10.3389/FNEUR.2021.753753
  40. Salem, N. A., El-Shamarka, M., Khadrawy, Y., & El-Shebiney, S. (2018). New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy. Inflammopharmacology, 26(4), 963-972. https://doi.org/10.1007/S10787-018-0456-2
  41. Sayed, N., Liu, C., & Wu, J. C. (2016). Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. Journal of the American College of Cardiology, 67(18), 2161–2176. https://doi.org/10.1016/J.JACC.2016.01.083
  42. Shaefi, S., & Harkness, W. (2003). Current Status of Surgery in the Management of Epilepsy. Epilepsia, 44(SUPPL. 1), 43–47. https://doi.org/10.1046/J.1528-1157.44.S.1.15.X
  43. Sirven J. I. (2015). Epilepsy: A Spectrum Disorder. Cold Spring Harbor perspectives in medicine, 5(9), a022848. https://doi.org/10.1101/cshperspect.a022848
  44. Szczepanik, E., Mierzewska, H., Antczak-Marach, D., Figiel-Dabrowska, A., Terczynska, I., Tryfon, J., Krzesniak, N., Noszczyk, B. H., Sawicka, E., Domanska-Janik, K., & Sarnowska, A. (2020). Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy. Stem Cells International, 2020. https://doi.org/10.1155/2020/7104243
  45. Thodeson, D. M., Brulet, R., & Hsieh, J. (2018). Neural stem cells and epilepsy: functional roles and disease-in-a-dish models. Cell and Tissue Research, 371(1), 47–54. https://doi.org/10.1007S00441-017-2675-Z
  46. Thompson, K., Kanemori, M., Kimes, E., Hobbs, E., Phan, J., Wilson, T., Wertheimer, A., Yoshida, T., Flores-Barnett, D., Kang, M., & Auyang, C. (2023). Transplantation of neurogenic-fusionogenic embryonic stem cells modified to overexpress GABA into a model of temporal lobe epilepsy: Promises and potential pitfalls. Medical Research Archives, 11(10). https://doi.org/10.18103/MRA.V11I10.4510
  47. Upadhya, D., Hattiangady, B., Castro, O. W., Shuai, B., Kodali, M., Attaluri, S., Bates, A., Dong, Y., Zhang, S. C., Prockop, D. J., & Shetty, A. K. (2019). Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proceedings of the National Academy of Sciences of the United States of America, 116(1), 287–296. https://doi.org/10.1073/PNAS.1814185115/-/DCSUPPLEMENTAL
  48. Vezzani, A., Balosso, S., & Ravizza, T. (2019). Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nature Reviews. Neurology, 15(8), 459–472. https://doi.org/10.1038/ S41582-019-0217-X
  49. Vizoso, F. J., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017). Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. International Journal of Molecular Sciences, 18(9). https://doi.org/10.3390/IJMS18091852
  50. Voskuyl, R. A., & Clinckers, R. (2009). ANTIEPILEPTIC DRUGS | Pharmacological Approaches for the Assessment of Antiepileptic Drug Efficacy in Experimental Animal Models. Encyclopedia of Basic Epilepsy Research, 90–97. https://doi.org/10.1016/B978-012373961-2.00235-6
  51. Wang, L., Zhao, Y., Pan, X., Zhang, Y., Lin, L., Wu, Y., Huang, Y., & He, H. (2021). Adipose-derived stem cell transplantation improves learning and memory via releasing neurotrophins in rat model of temporal lobe epilepsy. Brain Research, 1750. https://doi.org/10.1016/J.BRAINRES.2020.147121
  52. Wesselschmidt, R. L. (2012). Embryonic Stem Cells and Neurogenesis. Neural Development and Stem Cells: Third Edition, 31–59. https://doi.org/10.1007/978-1-4614-3801-4_2
  53. Xian, P., Hei, Y., Wang, R., Wang, T., Yang, J., Li, J., Di, Z., Liu, Z., Baskys, A., Liu, W., Wu, S., & Long, Q. (2019). Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics, 9(20), 5956–5975. https://doi.org/10.7150/THNO.33872
  54. Xu, K., Liu, F., Xu, W., Liu, J., Chen, S., & Wu, G. (2019). Transplanting GABAergic Neurons Differentiated from Neural Stem Cells into Hippocampus Inhibits Seizures and Epileptiform Discharges in Pilocarpine-Induced Temporal Lobe Epilepsy Model. World Neurosurgery, 128, e1–e11. https://doi.org/10.1016/J.WNEU.2019.01.245